Robert Saiz is an accomplished professional in the field of diagnostics and regulatory affairs, currently serving as the Global Head of Diagnostics - Portfolio Strategy for IVDs/Devices & Regulatory Affairs at BioNTech SE since April 2023. With extensive experience, previous roles include GRA Device Team Leader at Sanofi Genzyme, where Saiz was recognized as a subject matter expert in diagnostics platforms, and a consultant at RTS Consulting Services specializing in device product development and regulatory submissions. Saiz has a strong background in research and product development, having led teams at organizations such as Enigma Diagnostics, Roka Bioscience, Nanogen, and Althea Technologies. An educational foundation in clinical research and regulatory affairs complements Saiz's expertise, including a Master's degree from UC San Diego and a Bachelor's degree in Cell/Cellular and Molecular Biology from San Diego State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices